Journal Information
Most often read
118
Online surgical education adopted among urology residency programs in response to COVID-19: A pilot studyZ.M. Connelly, R. Abou Ghayda, T. Paneque, J. Gómez Rivas, F. Esperto, A. Azzawe, J. Orzel, M. Kathrins, ... N. Khater
Actas Urol Esp. 2022;46:536-43
118
115
Acute isolated orchalgia as the initial symptom in thoracic cord disorder: 2 case report and literature reviewI.-C. Kao, W.-H. Chen, H.-L. Yin
Actas Urol Esp. 2022;46:531-5
115
76
The impact of COVID-19 pandemic on reconstructive urologic surgery and andrology Spanish units’ practice during the state of alarm in 2020: National surveyP. Calleja Hermosa, F. Campos-Juanatey, R. García-Baquero, J. Ponce de Leon Roca, J.I. Martínez-Salamanca
Actas Urol Esp. 2022;46:640-5
76
15
Impact of aging on the incidence and mortality of urological cancers: 20-year projection in SpainF. Gómez-Palomo, J.V. Sánchez González, A. Bernal Gómez, J. Pérez Ardavín, J.L. Ruíz Cerdá
Actas Urol Esp. 2022;46:268-74
15
15
Non-metastatic castration-resistant prostate cancer: management recommendationsA. Alcaraz Asensio, J.L. Alvarez Ossorio, J.M. Cozar Olmo, V. Chantada Abal, A. Juarez Soto, E. Linares Espinos, J. Moreno Jimenez, J. Muñoz Rodriguez, ... A. Vilaseca
Actas Urol Esp. 2022;46:193-213
15
13
A novel model using computed tomography parameters to predict shock wave lithotripsy success in ureteral stones at different locationsF. Akkaş, M.G. Culha, A. Ayten, Y.O. Danacıoğlu, Ö. Yildiz, E. İnci, E. Guner, S. Şahin
Actas Urol Esp. 2022;46:114-21
13
10
Is Guy’s stone score useful for predicting outcomes in percutaneous nephrolithotomy?M. Lopez Silva, H. Sanguinetti, L. Padial Tagliapietra, J. Aguilar, N. Bernardo
Actas Urol Esp. 2022;46:92-7
10
10
Optimizing treatment for non muscle-invasive bladder cancer with an appP. Beardo, R. Pinto, H. Ayerra, J. Agüera, S. Armijos, J.L. Álvarez-Ossorio
Actas Urol Esp. 2022;46:230-7
10
8
Optimal patient position for percutaneous nephrolithotomy in horseshoe kidneys: Traditional prone or supine?T. Kargı, M. Ekşi, S. Karadağ, İ. Evren, A. Hacıislamoğlu, H. Polat, Y. Arikan, D.N. Özlü, ... A.İ. Taşçı
Actas Urol Esp. 2022;46:565-71
8
8
Systematic review on active treatment for urinary fistula after partial nephrectomyR. Massouh Skorin, A. Mahfouz, P. Escovar la Riva
Actas Urol Esp. 2022;46:387-96
8
7
What are the factors affecting glanular dehiscence after hypospadias surgery?R. Karabulut, Z. Turkyilmaz, A. Atan, C. Kaya, K. Sonmez
Actas Urol Esp. 2022;46:4-15
7
6
Impact of a radical prostatectomy on the urodynamic results of prostate cancer patients treated with intensity modulated radiation therapyJ. Casas-Nebra, B. Blanco-Gomez, A. Medina-González, I. Formoso-Garcia, S. Escaf-Barmadah, A. Alvarez-Arenal
Actas Urol Esp. 2022;46:431-41
6
5
Single-port robot-assisted retroperitoneal surgery: A feasible approachD. Vazquez-Martul, J.L. Ponce Diaz-Reixa, A. Barbagelata-Lopez, V. Chantada-Abal
Actas Urol Esp. 2022;46:653-7
5
5
Comparison of urology residency training between the United States and ChinaY.G. Jiang, M. Colaco, X.P. Hu, A. Atala, X.D. Zhang, J.H. Zhang, W.X. Zhao
Actas Urol Esp. 2022;46:367-76
5
5
Multicenter study on multidisciplinary committees in advanced prostate cancerM. Belda-Ferre, A. Garcia-Segui, J.J. Pacheco-Bru, V.J. Valencia-Guadalajara, L.P. Verdú-Verdú, E. Sánchez-Cano, F.S. Chillón-Sempere, F. Vázquez-Mazón
Actas Urol Esp. 2022;46:106-13
5
5
Predictive factors for mortality and intensive care unit admission in patients with emphysematous pyelonephritis: 5-year experience in a tertiary care hospitalJ.G. Arrambide-Herrera, J.I. Robles-Torres, M.A. Ocaña-Munguía, R. Romero-Mata, A. Gutiérrez-González, L.S. Gómez-Guerra
Actas Urol Esp. 2022;46:98-105
5
5
Clinical utility of the maximum area of detrusor tracing measurement in the urodynamic studies in pediatric population diagnosed with neuropathic bladder: A pilot studyA. Costa-Roig, J.A. March-Villalba, Al. Costa-Roig, M. Del Peral Samaniego, L. Rodríguez Caraballo, M.Á. Conca Baenas, A. Polo Rodrigo, A. Serrano Durbá, I. Diéguez Hernández-Vaquero
Actas Urol Esp. 2022;46:122-9
5
4
Incidence, prevalence, and treatment patterns in metastatic hormone-sensitive prostate cancer in Spain: ECHOS studyG. de Velasco Oria de Rueda, A.C. Plata Bello, M. Landeira, M. Mateo, P. Anguita, A. Pranzo, R. Snijder, A. Garnham, I. Hernández
Actas Urol Esp. 2022;46:557-64
4
4
Prognostic nutritional index is an independent prognostic factor for treatment response, survival and drug choice in metastatic castration-resistant prostate cancer treated with abiraterone acetate or enzalutamideA. Küçükarda, A. Gökyer, İ. Gökmen, E. Özcan, M.B. Hacıoğlu, B. Erdoğan, S. Uzunoğlu, İ. Çiçin
Actas Urol Esp. 2022;46:301-9
4
4
A 20-year experience in cadaveric pediatric en bloc kidney transplantation in adult recipientsJ.A. López-González, M. Beamud-Cortés, L. Bermell-Marco, M.A. Pérez-Martínez, M.D. Cuenca-Ramírez, L.M. Moratalla-Charcos, J. Planelles-Gómez, M. Sánchez-Sanchís, J.F. Vidal-Moreno
Actas Urol Esp. 2022;46:85-91
4